Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter

Journal of Hepatology

Volumn 67, Issue 3, 2017, Pages 577-584

  Wong, Vincent Wai Sun ^a   Petta, Salvatore ^b   Hiriart, Jean Baptiste ^c   Cammà, Calogero ^b   Wong, Grace Lai Hung ^a   Marra, Fabio ^d   Vergniol, Julien ^c   Chan, Anthony Wing Hung ^a   Tuttolomondo, Antonino ^b   Merrouche, Wassil ^c   Chan, Henry Lik Yuen ^a   Le Bail, Brigitte ^e,f   Arena, Umberto ^d   Craxì, Antonio ^b   de Lédinghen, Victor ^c,e  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF PALERMO   (Italy)

^c HAUT LÉVÊQUE HOSPITAL   (France)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f HÔPITAL PELLEGRIN   (France)

Author keywords

Diagnostic accuracy; FibroScan; Hepatic steatosis; Liver biopsy; Liver stiffness measurement; Non alcoholic fatty liver disease

Indexed keywords

ADULT; ARTICLE; ATTENUATION; AUTOIMMUNE HEPATITIS; BODY MASS; CHOLESTATIC HEPATITIS; CHRONIC HEPATITIS; CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; EUROPE; FATTY LIVER; FEMALE; HONG KONG; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRANSIENT ELASTOGRAPHY; VALIDITY; AGED; BIOPSY; ELASTOGRAPHY; LIVER; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY;

ADULT; AGED; BIOPSY; CROSS-SECTIONAL STUDIES; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 85020777481     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2017.05.005     Document Type: Article

References (37)

1. Younossi, Z.M., Koenig, A.B., Abdelatif, D., Fazel, Y., Henry, L., Wymer, M., Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64 (2016), 73–84.
2. Wong, V.W., Chu, W.C., Wong, G.L., Chan, R.S., Chim, A.M., Ong, A., et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 61 (2012), 409–415.
3. Wong, R.J., Aguilar, M., Cheung, R., Perumpail, R.B., Harrison, S.A., Younossi, Z.M., et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 148 (2015), 547–555.
4. Younossi, Z.M., Otgonsuren, M., Henry, L., Venkatesan, C., Mishra, A., Erario, M., et al. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology 62 (2015), 1723–1730.
5. Wong, G.L., Wong, V.W., Choi, P.C., Chan, A.W., Chim, A.M., Yiu, K.K., et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut 58 (2009), 111–117.
6. Veldt, B.J., Chen, W., Heathcote, E.J., Wedemeyer, H., Reichen, J., Hofmann, W.P., et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 47 (2008), 1856–1862.
7. Chen, C.L., Yang, H.I., Yang, W.S., Liu, C.J., Chen, P.J., You, S.L., et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 135 (2008), 111–121.
8. Chan, A.W., Wong, G.L., Chan, H.Y., Tong, J.H., Yu, Y.H., Choi, P.C., et al. Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B. J Gastroenterol Hepatol, 2016.
9. Sasso, M., Tengher-Barna, I., Ziol, M., Miette, V., Fournier, C., Sandrin, L., et al. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan((R)): validation in chronic hepatitis C. J Viral Hepat 19 (2012), 244–253.
10. de Ledinghen, V., Vergniol, J., Foucher, J., Merrouche, W., le Bail, B., Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int 32 (2012), 911–918.
11. Chon, Y.E., Jung, K.S., Kim, S.U., Park, J.Y., Park, Y.N., Kim, D.Y., et al. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population. Liver Int 34 (2014), 102–109.
12. Shen, F., Zheng, R.D., Mi, Y.Q., Wang, X.Y., Pan, Q., Chen, G.Y., et al. Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients. World J Gastroenterol 20 (2014), 4702–4711.
13. Myers, R.P., Pollett, A., Kirsch, R., Pomier-Layrargues, G., Beaton, M., Levstik, M., et al. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int 32 (2012), 902–910.
14. Boursier, J., Zarski, J.P., de Ledinghen, V., Rousselet, M.C., Sturm, N., Lebail, B., et al. Determination of reliability criteria for liver stiffness evaluation by transient elastography. Hepatology 57 (2013), 1182–1191.
15. Kwok, R., Choi, K.C., Wong, G.L., Zhang, Y., Chan, H.L., Luk, A.O., et al. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study. Gut 65 (2016), 1359–1368.
16. de Ledinghen, V., Vergniol, J., Capdepont, M., Chermak, F., Hiriart, J.B., Cassinotto, C., et al. Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations. J Hepatol 60 (2014), 1026–1031.
17. Karlas, T., Petroff, D., Sasso, M., Fan, J.G., Mi, Y.Q., de Ledinghen, V., et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol 66 (2017), 1022–1030.
18. Wong, V.W., Wong, G.L., Yeung, D.K., Lau, T.K., Chan, C.K., Chim, A.M., et al. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. J Hepatol 62 (2015), 182–189.
19. Kleiner, D.E., Brunt, E.M., Van Natta, M., Behling, C., Contos, M.J., Cummings, O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005), 1313–1321.
20. Wong, V.W., Vergniol, J., Wong, G.L., Foucher, J., Chan, H.L., Le Bail, B., et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51 (2010), 454–462.
21. Younossi, Z.M., Stepanova, M., Rafiq, N., Makhlouf, H., Younoszai, Z., Agrawal, R., et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology 53 (2011), 1874–1882.
22. Ekstedt, M., Hagstrom, H., Nasr, P., Fredrikson, M., Stal, P., Kechagias, S., et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 61 (2015), 1547–1554.
23. Hanley, J.A., McNeil, B.J., The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143 (1982), 29–36.
24. Imajo, K., Kessoku, T., Honda, Y., Tomeno, W., Ogawa, Y., Mawatari, H., et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology 150 (2016), 626–637 e627.
25. Wong, G.L., Wong, V.W., Choi, P.C., Chan, A.W., Chim, A.M., Yiu, K.K., et al. Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B. J Gastroenterol Hepatol 24 (2009), 1002–1007.
26. Millonig, G., Reimann, F.M., Friedrich, S., Fonouni, H., Mehrabi, A., Buchler, M.W., et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 48 (2008), 1718–1723.
27. Millonig, G., Friedrich, S., Adolf, S., Fonouni, H., Golriz, M., Mehrabi, A., et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol 52 (2010), 206–210.
28. Wong, G.L., Chan, H.L., Choi, P.C., Chan, A.W., Lo, A.O., Chim, A.M., et al. Association between anthropometric parameters and measurements of liver stiffness by transient elastography. Clin Gastroenterol Hepatol 11 (2013), 295–302 e291–e293.
29. Shen, F., Zheng, R.D., Shi, J.P., Mi, Y.Q., Chen, G.F., Hu, X., et al. Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease. Liver Int 35 (2015), 2392–2400.
30. Merriman, R.B., Ferrell, L.D., Patti, M.G., Weston, S.R., Pabst, M.S., Aouizerat, B.E., et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology 44 (2006), 874–880.
31. Myers, R.P., Pomier-Layrargues, G., Kirsch, R., Pollett, A., Duarte-Rojo, A., Wong, D., et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 55 (2012), 199–208.
32. de Ledinghen, V., Wong, V.W., Vergniol, J., Wong, G.L., Foucher, J., Chu, S.H., et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan(R). J Hepatol 56 (2012), 833–839.
33. Wong, V.W., Vergniol, J., Wong, G.L., Foucher, J., Chan, A.W., Chermak, F., et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 107 (2012), 1862–1871.
34. Sasso, M., Audiere, S., Kemgang, A., Gaouar, F., Corpechot, C., Chazouilleres, O., et al. Liver steatosis assessed by controlled attenuation parameter (CAP) measured with the XL probe of the fibroscan: a pilot study assessing diagnostic accuracy. Ultrasound Med Biol 42 (2016), 92–103.
35. Noureddin, M., Lam, J., Peterson, M.R., Middleton, M., Hamilton, G., Le, T.A., et al. Utility of magnetic resonance imaging vs. histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 58 (2013), 1930–1940.
36. Park, C.C., Nguyen, P., Hernandez, C., Bettencourt, R., Ramirez, K., Fortney, L., et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology 152 (2017), 598–607 e592.
37. Lin, S.C., Heba, E., Wolfson, T., Ang, B., Gamst, A., Han, A., et al. Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat using a new quantitative ultrasound technique. Clin Gastroenterol Hepatol 13 (2015), 1337–1345 e1336.